Senator Jeanne Shaheen (D-NH) states the talks in Oman are a good sign & that negotiations are always better than fighting when discussing the State Department calling Americans to leave Iran immediately. She also talks about the importance of her legislation on rare earth minerals in regards to competition with China, and calls for reforms that address the concerns of how ICE agents operate. Senator Shaheen speaks with Joe Mathieu on the late edition of Bloomberg's "Balance of Power."

See omnystudio.com/listener for privacy information.

Tom Freston, Principal of Firefly3 and former CEO of Viacom, on the media lansscape and his new memoir, “Unplugged: Adventures from MTV to Timbuktu." He is joined by Bloomberg's Tim Stenovec and Carol Massar.

See omnystudio.com/listener for privacy information.

BlackRock Fixed Income CIO Rick Rieder sits with Bloomberg's Matt Miller and Dani Burger to talk the current state of the markets and the lack of data due to the brief US Government shutdown.

See omnystudio.com/listener for privacy information.

Atlanta Fed President Raphael Bostic sits with Bloomberg's Michael McKee in Atlanta to discuss inflation, Jerome Powell, and more.

See omnystudio.com/listener for privacy information.

Brooks Running CEO Dan Sheridan joins Carol Massar and Tim Stenovec on "Bloomberg Businessweek Daily" to talk about the potential growth in the footwear market and how China could be a potential player as consumers.

See omnystudio.com/listener for privacy information.

New York Representative Nicole Malliotakis (R) joins Joe Mathieu on "Balance of Power" to talk about the looming government funding deadline and the continued debate over ICE.

See omnystudio.com/listener for privacy information.

Qualcomm CEO Cristiano Amon joins "Bloomberg Tech" to talk about the outlook for the company with rising memory costs and component shortages.

See omnystudio.com/listener for privacy information.

Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

See omnystudio.com/listener for privacy information.